Nuvation Bio Deal History & Licensing Activity
Nuvation Bio is a biotech. The company currently has 7 active clinical trials, primarily in Solid Tumors.
Deals (12mo)
1
Active Trials
7
Top Modality
N/A
Focus Area
Solid Tumors
Nuvation Bio Pipeline Focus
Therapeutic areas and modalities where Nuvation Bio is most active based on deal history and clinical trial data.
Therapeutic Areas
Nuvation Bio Clinical Pipeline
Nuvation Bio has 7 active clinical trials across 4 development phases.
1
Unknown
1
Phase 1
2
Phase 2
3
Phase 3
See How Your Asset Matches Nuvation Bio's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Nuvation Bio Licensing & Deal Activity
Nuvation Bio is a biotech company that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Nuvation Bio include Solid Tumors (5 deals and trials), and CNS Disorders (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Nuvation Bio and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Nuvation Bio's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.